Bio Medica Laboratories IPO

Forthcoming

Bio Medica Laboratories IPO Details

  • Bidding Date

    21-May-2026 to
    25-May-2026

  • Issue Size

    ₹52.43 Cr

  • Price Band

    ₹132 to ₹139

  • Allotment date

    26-May-2026

  • Listing date

    To be updated

  • Lot size

    1000

  • No. of shares

    37,72,000

  • Fresh issue/OFS

    ₹47.19 Cr/₹5.24 Cr

About Bio Medica Laboratories Company

Bio Medica Laboratories was founded in 1988 by Pradeep Johari and has developed from a pharmaceutical manufacturing background into a broader lab-testing and quality-assurance business focused on regulated healthcare support. Its core activities now center on pharmaceutical testing, microbiological analysis, water testing, method validation, and stability studies, serving pharmaceutical companies, healthcare providers, and manufacturers that need compliant product and process verification. The company’s expertise includes work across IP, BP, USP, and WHO standards, with strengths in precision testing, documentation, and the use of modern instrumentation to deliver reliable results. Its approach is built around scientific rigor, regulatory compliance, and client support, helping customers manage quality, safety, and consistency across pharmaceutical and related products.

Subscription Status

  • Category

    Status

  • QIBs

    --

  • NIIs

    --

  • Retail

    --

  • Others

    --

  • Total

    --

ipo banner

Recent IPOs

Name Price Band (Rs) Bidding Date
NFP Sampoorna Foods 52 - 55 18-May-2026 to 20-May-2026
M R Maniveni Foods 51 - 52 22-May-2026 to 26-May-2026
Autofurnish Trading 41 21-May-2026 to 25-May-2026
Q-Line Biotech 326 - 343 21-May-2026 to 25-May-2026
IPO MonitorIPO Monitor

FAQs for Bio Medica Laboratories IPO.

The issue size of Bio Medica Laboratories is ₹52.43 Cr.

Bio Medica Laboratories falls into Pharmaceuticals industry.

The open and close dates for the Bio Medica Laboratories are 21-May-2026 & 25-May-2026.

The price band for the Bio Medica Laboratories ipo is ₹132 to ₹139

The purpose of this IPO is to raise fresh capital as well as enable the existing shareholders to sell their stake.

Key financial of the Bio Medica Laboratories are:


Bio Medica Laboratories FY-25 FY-24 FY-23
Revenue (₹ Cr) 38.2 15.25 16.23
EBIT (₹ Cr) 14.37 4.52 1.2
Proft after Tax (₹ Cr) 9.79 2.5 0.33
Debt (₹ Cr) 15.01 10.49 9.61
Net Worth (₹ Cr) 14.73 4.94 2.44
RoE (%) 66.48 50.6 13.67